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From July through September 2000, patients in five European
countries were infected with a multidrug-resistant strain of Sal-
monella  Typhimurium  DT204b. Epidemiologic investigations
were facilitated by the transmission of electronic images
(Tagged Image Files) of pulsed-field gel electrophoresis pro-
files. This investigation highlights the importance of standard-
ized protocols for molecular typing in international outbreaks of
foodborne disease.
The Study
From July through September 2000, patients in five Euro-
pean countries (England, Scotland, Germany, the Netherlands,
and Iceland) were infected with a strain of Salmonella enterica
serotype Typhimurium definitive phage type (DT) 204b; the
strain was resistant to ampicillin (A), chloramphenicol (C),
gentamicin (G), kanamycin (K), streptomycin (S), sulphona-
mides (Su), tetracyclines (T), trimethoprim (Tm), and nalidixic
acid (Nx). The strain also had decreased susceptibility to
ciprofloxacin (CpL), with an MIC by E-test of 0.38 mg/L (1,2).
Over 350 laboratory-confirmed cases were recognized. Epide-
miologic investigations implicated shredded lettuce as the
vehicle of infection (1).
Isolates from patients in Iceland, the Netherlands, and
Scotland were referred to the England and Wales Public
Health Laboratory Service (PHLS) Laboratory of Enteric
Pathogens for phage typing and antibiogram analysis. These
isolates were compared with those from a concurrent outbreak
of multiresistant S. Typhimurium DT204b in northeastern
England and from patients returning to England and Wales
after visiting other European countries. A panel of seven iso-
lates from outbreaks in England, Scotland, Iceland, and the
Netherlands and from patients returning to the United King-
dom after visiting Greece, Germany, and the Netherlands were
further characterized by a variety of molecular techniques,
including plasmid profile typing, pulsed-field gel electro-
phoresis (PFGE), fluorescent amplified fragment-length poly-
morphism fingerprinting (FAFLP), and integron typing;
specific resistance genes were characterized by polymerase
chain reaction (PCR) and the mutation conferring decreased
susceptibility to ciprofloxacin was identified by a LightCycler
(Roche Diagnostics Ltd., Lewes, U.K.) gyrA mutation assay
(GAMA) (3). Isolates from Germany and Scotland were typed
independently with the same phenotypic methods as those
used in the Laboratory of Enteric Pathogens and also by plas-
mid profile typing and PFGE. To facilitate epidemiologic
investigations, PFGE Tagged Image Files (TIFs) of banding
patterns of isolates from England, Scotland, and Germany
were exchanged electronically.
Conjugation experiments were performed at both 28°C and
37°C by using a rifampicin-resistant strain of Escherichia coli
(strain 20R764) as the recipient. Resultant plasmids were clas-
sified by incompatibility. DNA was extracted from transconju-
gants by using a DNeasy tissue kit (Qiagen Ltd., Crawley,
U.K.). For plasmid profile analysis, plasmids were resolved by
electrophoresis at 110 V for 3 hours in 0.8% wt/vol agarose.
Oligonucleotide primers synthesized by MWG-Biotech UK
Ltd. (Milton Keynes, U.K.) were used to detect the antibiotic
resistance genes aadA2, blaCARB-2, blaTEM, sul1, tetA (class
A), tetA (class G), tetA (class B), and integrons in both wild-
type strains and E. coli K12 transconjugants. The nucleotide
sequence of these primers and the corresponding temperature
profiles for amplification have been described (4). GAMA,
designed to detect three different gyrA mutations, was per-
formed in a LightCycler instrument under previously
described reaction components and conditions (3). For PFGE,
agarose plugs were prepared by the method of Powell et al. (5)
with 2% chromosomal grade agarose (Bio-Rad Laboratories,
Hemel Hempstead, U.K.) replacing the 2% Type VII LGT aga-
rose (Sigma Chemical Co., Poole, U.K.). Samples were run
through a 1% pulsed-field certified agarose gel (Bio-Rad) at
180 V for 44 hours, with pulse times ramped from 6 to 72 sec-
onds. For FAFLP, the selective primer combinations Eco+0
Mse+T, Eco+0 Mse+TA, and Eco+0 Mse+CG were used, and
gel separation and fragment analyses were performed, all as
described by Scott et al. (6). 
All seven isolates had phage typing reactions correspond-
ing to S. Typhimurium DT204b. This rare phage type was
reported in only 40 cases in England and Wales in the 5-year
period 1996–2000 and had never been identified in Iceland
before this epidemic. 
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With the exception of resistance to nalidixic acid and
decreased susceptibility to ciprofloxacin, the complete resis-
tance spectrum (ACGKSSuTTm) was transferable to E. coli
K12 rif r as an intact linkage group. Plasmid profile analysis
demonstrated the presence of five plasmids of 120, 65, 4.0,
3.0, and 2.0 MDa. Most transconjugants with the resistance
pattern ACGKSSuTTm had a single incompatibility group H2
plasmid of 120 MDa. A few transconjugants had both the 120-
MDa plasmid and an additional plasmid of 65 MDa. When
PCR amplification was performed on DNA from transconju-
gants harboring either the single 120-MDa plasmid or both the
120-MDa and 65-MDa plasmids, positive results for aadA2,
blaTEM, sul1, and tetA (class A) were obtained; blacarb-2, tetA
(class G), and tetA (class B) were negative. When studied by
integron PCR, one discrete 1.6-kb band was generated in
transconjugants when either the 120-MDa plasmid or both the
120-MDa and the 65-MDa plasmids were present. In addition,
one very faint amplicon of approximately 4 kb was consis-
tently produced. Whether both the 120-Mda plasmid and the
65 Mda-plasmid have tetracycline resistance genes or whether
tetracycline resistance is encoded by only the 120-MDa plas-
mid is unclear. When studied by GAMA, the gyrA mutation
was that of aspartate to glycine (GAC-GGC) at codon 87. 
PFGE profiles of all seven isolates were indistinguishable
(Figure). To facilitate epidemiologic investigations, PFGE and
plasmid profile TIFs of the banding patterns of these isolates
and those of multiresistant S.  Typhimurium DT204b from
Scotland and Germany were exchanged electronically. In all
cases, the resultant PFGE and plasmid profiles were indistin-
guishable. Finally, when studied by FAFLP, the seven isolates
were identical. 
Conclusions
These results confirm that the strains of S. Typhimurium
DT204b of R-type ACGKSSuTTmNxCpL responsible for out-
breaks of infection in five European countries in the summer of
2000 were indistinguishable by all phenotypic and molecular
criteria used for their characterization. A key aspect of this
investigation was the rapid exchange of molecular fingerprints
between laboratories already using standardized phage typing
and antimicrobial susceptibility testing. In the United States, the
exchange of molecular data has been addressed by the establish-
ment of PulseNet, a national molecular typing scheme based on
a standard method for PFGE; a similar network is being set up
for the major Salmonella reference laboratories in Europe with
research funding from the European Commission. Developing
compatible networks for the exchange of real-time molecular
data for S. enterica on an intercontinental scale would be of
major benefit for the global control of salmonellosis.
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